Rollins' Stock Performance Versus the S&P 500
Money

Rollins' Stock Performance Versus the S&P 500

authorBy Bola Sokunbi
DateMar 16, 2026
Read time3 min

Rollins, Inc. (ROL), a significant entity in the global consumer and commercial services sector, is recognized for its comprehensive pest and wildlife control services, alongside protection against various nuisances like termites, rodents, and insects, catering to both residential and commercial clientele. The company boasts an impressive market capitalization of $26.5 billion, firmly placing it within the large-cap stock category. Rollins' market position is fortified by its diverse service offerings, the formidable reputation of its Orkin brand, which ensures strong customer loyalty, and an extensive operational network complemented by robust training programs that effectively deter new market entrants.

However, despite its inherent strengths, ROL's stock has recently shown signs of underperformance when measured against the broader S&P 500 Index. Following its 52-week peak of $66.14 reached on February 11, the stock has experienced a 16.6% decline. Over the past three months, ROL shares have fallen by 8.2%, contrasting with the S&P 500's more modest 2.9% drop during the same period. This trend of underperformance extends to a six-month view, where ROL shares depreciated by 3.9%, and over the last 52 weeks, they recorded an 8.7% gain, significantly trailing the S&P 500's 20.1% return. Technical analysis further indicates a bearish trajectory, with the stock trading below its 200-day moving average since early March and its 50-day moving average since mid-February. A primary factor contributing to this dip was an unseasonably warm winter, which negatively affected demand for one-time pest control services. The release of Rollins' Q4 results on February 11, which reported an adjusted EPS of $0.25 and revenue of $912.9 million, both falling short of Wall Street's projections of $0.27 and $922.1 million respectively, led to a 10.5% drop in share price during the subsequent trading session.

In the competitive landscape of personal services, Rollins maintains a strong position relative to some peers, such as E-Home Household Service Holdings Limited (EJH), which has seen a substantial 90.8% decline over six months and a staggering 99.8% loss over the past year. Looking forward, Wall Street analysts generally hold a positive outlook for ROL, with a consensus "Moderate Buy" rating from 16 analysts. The average price target of $64.99 suggests a potential upside of 17.9% from its current trading levels, indicating a belief in the company's long-term recovery and growth potential.

The journey of a company like Rollins, navigating market fluctuations and seasonal impacts, underscores the dynamic nature of investments. While short-term performance may face headwinds, the foundational strengths of a well-established brand, diversified services, and a robust operational framework often pave the way for sustained success. Investors can look at the resilience and adaptability of such enterprises, recognizing that temporary setbacks can present opportunities for future growth and value creation.

More Articles
Abbott Laboratories Introduces Advanced XIENCE Skypoint Stent in India for Enhanced Cardiovascular Care
Abbott Laboratories has launched its cutting-edge XIENCE Skypoint stent in India, aiming to revolutionize cardiovascular treatment. This advanced stent offers superior flexibility and maneuverability, enabling physicians to address complex blockages and reach challenging arterial areas. The initiative seeks to provide comprehensive solutions for long-term heart health, offering doctors more versatile treatment options and patients increased confidence in their cardiac care. Abbott, a global healthcare leader, continues its commitment to innovation across medical devices, diagnostics, pharmaceuticals, and nutritional products.
By T. Harv EkerMar 15, 2026
Thermo Fisher Scientific Eyes Future Expansion Driven by AI and Strategic Acquisitions
Thermo Fisher Scientific Inc. (TMO) is strategically positioned for significant growth in the coming years, propelled by its increasing integration of artificial intelligence into operations and a strong focus on mergers and acquisitions. CEO Marc Casper, at the 47th Annual Raymond James Institutional Investor Conference on March 3, 2026, outlined the company's robust strategic outlook, targeting 3% to 4% growth for 2026 and a long-term expansion rate of 5% to 6%. The company's ongoing acquisition of Olink is a key part of its strategy to enhance endpoint solution capabilities and deliver increased value to customers.
By Mr. Money MustacheMar 15, 2026
Jeff Bezos's Strategic Guide to Decision-Making: Two Key Questions for Business Leaders
Jeff Bezos, the founder of Amazon, emphasized that decision-making should not be a one-size-fits-all process. He advocated for a nuanced approach, categorizing decisions into two types based on their consequences and reversibility. This method aims to maintain operational speed within growing organizations by streamlining low-stakes, reversible choices while ensuring careful deliberation for high-impact, irreversible ones. His framework continues to influence leadership at Amazon and aligns with economic principles on the value of flexibility.
By Chika UwazieMar 15, 2026
Pfizer's New Antibody Drug Shows Promising Results in Atopic Dermatitis Trial
Pfizer Inc. has reported positive Phase 2 trial results for its tri-specific antibody, tilrekimig, targeting atopic dermatitis. The drug demonstrated superior efficacy compared to an existing treatment, bolstering Pfizer's position in immunology. BMO analysts have reiterated an "Outperform" rating for Pfizer, citing these promising developments.
By Chika UwazieMar 15, 2026
Ares Capital Corporation (ARCC): A Prudent Investment Opportunity for High Yields
Ares Capital Corporation (ARCC) is presented as a compelling high-yield investment for 2026, driven by its robust position as a leading Business Development Company (BDC) with a diversified private credit portfolio. The company's disciplined underwriting and conservative risk management strategies enable it to navigate market challenges effectively, offering consistent distributions to investors. Despite potential concerns such as interest rate fluctuations and economic slowdowns, ARCC's floating-rate loans and rigorous valuation processes underscore its resilience and attractive income foundation.
By Mr. Money MustacheMar 15, 2026